← Back to Search

Behavioural Intervention

Digital Interventions for Mild Cognitive Impairment (MediDream Trial)

N/A
Recruiting
Led By David Ziegler, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 60-85 years old
Normal or corrected to normal visual and auditory acuity
Must not have
History of seizures
Macular degeneration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediate follow-up, and at a 6 month follow-up in a subset of participants
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test if a new digital meditation called MediTrain can improve cognitive abilities and sleep in patients with mild cognitive impairment.

Who is the study for?
This trial is for older adults who are experiencing mild cognitive impairment. Participants should be interested in testing digital interventions aimed at improving cognition, wellbeing, stress levels, and sleep quality.
What is being tested?
The study is examining the effectiveness of a digital meditation program called MediTrain. It also uses wrist-worn multi-sensor watches and sleep monitors to track improvements in participants' cognitive abilities and sleep patterns.
What are the potential side effects?
Since this trial involves non-invasive digital interventions and monitoring devices, significant side effects are not anticipated. However, some individuals may experience discomfort or skin irritation from wearing the devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 60 and 85 years old.
Select...
My vision and hearing are normal, or corrected to be normal.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of seizures.
Select...
I have macular degeneration.
Select...
I have strabismus.
Select...
I have received radiation seeds or implants.
Select...
I am currently taking medication for anxiety.
Select...
I have glaucoma.
Select...
I have a lazy eye.
Select...
I use a medication patch.
Select...
I have had a joint replacement surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediate follow-up, and at a 6 month follow-up in a subset of participants
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediate follow-up, and at a 6 month follow-up in a subset of participants for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean change in measures of stress reactivity over time
Mean change in sleep quality
Secondary study objectives
Mean change in Frontal Theta Power over time
Mean change in Telomere length (quantified in peripheral blood cells) over time
Mean change in resting state networks over time
+1 more
Other study objectives
Mean Change on Berlin Questionnaire
Mean Change on Epworth Sleepiness Scale
Mean Change on Everyday Cognition Scale (ECog)
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MediTrainExperimental Treatment3 Interventions

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,789 Previous Clinical Trials
28,188,242 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,587 Previous Clinical Trials
14,901,086 Total Patients Enrolled
David Ziegler, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
4,090 Total Patients Enrolled
~60 spots leftby Feb 2026